Your browser doesn't support javascript.
loading
Integrated Genotoxicity Testing of three anti-infective drugs using the TGx-DDI transcriptomic biomarker and high-throughput CometChip® assay in TK6 cells.
Buick, Julie K; Rowan-Carroll, Andrea; Gagné, Rémi; Williams, Andrew; Chen, Renxiang; Li, Heng-Hong; Fornace, Albert J; Chao, Christy; Engelward, Bevin P; Frötschl, Roland; Ellinger-Ziegelbauer, Heidrun; Pettit, Syril D; Aubrecht, Jiri; Yauk, Carole L.
Affiliation
  • Buick JK; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
  • Rowan-Carroll A; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
  • Gagné R; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
  • Williams A; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.
  • Chen R; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, United States.
  • Li HH; Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, DC, United States.
  • Fornace AJ; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, United States.
  • Chao C; Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, DC, United States.
  • Engelward BP; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, United States.
  • Frötschl R; Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, DC, United States.
  • Ellinger-Ziegelbauer H; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Pettit SD; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.
  • Aubrecht J; Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
  • Yauk CL; Bayer AG, Pharmaceuticals, Preclinical Development, Wuppertal, Germany.
Front Toxicol ; 4: 991590, 2022.
Article in En | MEDLINE | ID: mdl-36211197

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Toxicol Year: 2022 Document type: Article Affiliation country: Canadá

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Toxicol Year: 2022 Document type: Article Affiliation country: Canadá